These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2841762)

  • 1. NMDA receptor losses in putamen from patients with Huntington's disease.
    Young AB; Greenamyre JT; Hollingsworth Z; Albin R; D'Amato C; Shoulson I; Penney JB
    Science; 1988 Aug; 241(4868):981-3. PubMed ID: 2841762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excitatory amino acid binding sites in the caudate nucleus and frontal cortex of Huntington's disease.
    Dure LS; Young AB; Penney JB
    Ann Neurol; 1991 Dec; 30(6):785-93. PubMed ID: 1665055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotransmitter receptor alterations in Huntington's disease: autoradiographic and homogenate studies with special reference to benzodiazepine receptor complexes.
    Whitehouse PJ; Trifiletti RR; Jones BE; Folstein S; Price DL; Snyder SH; Kuhar MJ
    Ann Neurol; 1985 Aug; 18(2):202-10. PubMed ID: 2994554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excitatory amino acid binding sites in the hippocampal region of Alzheimer's disease and other dementias.
    Penney JB; Maragos WF; Greenamyre JT; Debowey DL; Hollingsworth Z; Young AB
    J Neurol Neurosurg Psychiatry; 1990 Apr; 53(4):314-20. PubMed ID: 2160518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzodiazepine receptors: the effect of GABA on their characteristics in human brain and their alteration in Huntington's disease.
    Reisine TD; Overstreet D; Gale K; Rossor M; Iversen L; Yamamura HI
    Brain Res; 1980 Oct; 199(1):79-88. PubMed ID: 6105905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative autoradiography of neurotransmitter receptors in Huntington disease.
    Penney JB; Young AB
    Neurology; 1982 Dec; 32(12):1391-5. PubMed ID: 6292789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease: changes in hippocampal N-methyl-D-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors--an autoradiographic study.
    Jansen KL; Faull RL; Dragunow M; Synek BL
    Neuroscience; 1990; 39(3):613-27. PubMed ID: 1965859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in L-glutamate binding in Alzheimer's and Huntington's diseases.
    Greenamyre JT; Penney JB; Young AB; D'Amato CJ; Hicks SP; Shoulson I
    Science; 1985 Mar; 227(4693):1496-9. PubMed ID: 2858129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ibotenic acid lesion of nucleus basalis magnocellularis differentially affects cholinergic, glutamatergic and GABAergic markers in cortical rat brain regions.
    Rossner S; Schliebs R; Bigl V
    Brain Res; 1994 Dec; 668(1-2):85-99. PubMed ID: 7704621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of cortical and hippocampal NMDA and PCP receptors following selective cortical and subcortical lesions.
    Maragos WF; Greenamyre JT; Chu DC; Penney JB; Young AB
    Brain Res; 1991 Jan; 538(1):36-45. PubMed ID: 1850317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscarinic, N-methyl-D-aspartate (NMDA) and benzodiazepine receptor binding sites in cortical membranes from amyotrophic lateral sclerosis patients.
    Gredal O; Pakkenberg B; Nielsen M
    J Neurol Sci; 1996 Nov; 143(1-2):121-5. PubMed ID: 8981309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective loss of [3H]kainic acid and [3H]AMPA binding in layer VI of frontal cortex in Huntington's disease.
    Wagster MV; Hedreen JC; Peyser CE; Folstein SE; Ross CA
    Exp Neurol; 1994 May; 127(1):70-5. PubMed ID: 7515353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered excitatory and inhibitory amino acid receptor binding in hippocampus of patients with temporal lobe epilepsy.
    McDonald JW; Garofalo EA; Hood T; Sackellares JC; Gilman S; McKeever PE; Troncoso JC; Johnston MV
    Ann Neurol; 1991 May; 29(5):529-41. PubMed ID: 1650160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased receptor-binding sites for kainic acid in brains of patients with Huntington's disease.
    London ED; Yamamura HI; Bird ED; Coyle JT
    Biol Psychiatry; 1981 Feb; 16(2):155-62. PubMed ID: 6452910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzodiazepine and GABA receptors in early Huntington's disease.
    Walker FO; Young AB; Penney JB; Dovorini-Zis K; Shoulson I
    Neurology; 1984 Sep; 34(9):1237-40. PubMed ID: 6087209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D-1 and D-2 receptors in Huntington's disease.
    Cross A; Rossor M
    Eur J Pharmacol; 1983 Mar; 88(2-3):223-9. PubMed ID: 6221936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of brain neurotransmitter receptor binding in Huntington's chorea.
    Enna SJ; Bennett JP; Bylund DB; Snyder SH; Bird ED; Iversen LL
    Brain Res; 1976 Nov; 116(3):531-7. PubMed ID: 10053
    [No Abstract]   [Full Text] [Related]  

  • 18. Quantitative autoradiographic localization of NMDA, quisqualate and PCP receptors in the frog tectum.
    McDonald JW; Cline HT; Constantine-Paton M; Maragos WF; Johnston MV; Young AB
    Brain Res; 1989 Mar; 482(1):155-8. PubMed ID: 2539881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoradiographic localisation of NMDA, quisqualate and kainic acid receptors in human spinal cord.
    Jansen KL; Faull RL; Dragunow M; Waldvogel H
    Neurosci Lett; 1990 Jan; 108(1-2):53-7. PubMed ID: 1689476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoradiographic localization of inhibitory and excitatory amino acid neurotransmitter receptors in human normal and olivopontocerebellar atrophy cerebellar cortex.
    Albin RL; Gilman S
    Brain Res; 1990 Jul; 522(1):37-45. PubMed ID: 2171714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.